Skip to main content


Fig. 1 | Parasites & Vectors

Fig. 1

From: A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection

Fig. 1

In vitro percentage PZQ released over time from solid lipid nanoparticle-PZQ formulations. In vitro release studies were performed to select SLN formulations with optimum physiochemical properties (Formulas 7, 8 and 9). This selection was performed using a USP dissolution tester, and aliquots were analysed spectrophotometrically. Values are presented as the means ± SD. Abbreviation: SLN-PZQ, praziquantel-loaded solid lipid nanoparticle

Back to article page